Instuitional Investor - Versant Venture Management, Llc

13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Monte Rosa Therapeutics Inc.	GLUE	3,180,780	$76,974,876	47.34%
2.	Century Therapeutics Inc.	IPSC	12,166,109	$29,806,967	18.33%
3.	Jade Biosciences Inc.	JBIO	991,783	$22,037,418	13.55%
4.	Lenz Therapeutics Inc.	LENZ	2,656,888	$15,091,124	9.28%
5.	Contineum Therapeutics Inc.	CTNM	542,628	$8,893,673	5.47%